As of 2025-03-26, the EV/EBITDA ratio of Proteome Sciences PLC (PRM.L) is -8.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRM.L's latest enterprise value is 24.40 mil GBP. PRM.L's TTM EBITDA according to its financial statements is -2.90 mil GBP. Dividing these 2 quantities gives us the above PRM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.0x - 22.0x | 15.0x |
| Forward P/E multiples | 8.1x - 11.1x | 8.5x |
| Fair Price | (12.20) - (15.07) | (15.77) |
| Upside | -400.5% - -471.1% | -488.4% |
| Date | EV/EBITDA |